MissionIR Articles
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Featured in Recent Power Play Interview
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, was spotlighted during a recent interview released by…
-
European Clinical Trial Site Expansion for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Brain Cancer Drug Candidate Drives Patient Enrollment
Innovative brain tumor therapy developer CNS Pharmaceuticals (NASDAQ: CNSP) is reporting continued expansion of the number of clinical site launches for its evaluation of the company’s lead product candidate for treating recurrent glioblastoma multiforme (“GBM”).…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Seeking to Solve Unmet Need for GBM Treatment
CNS Pharmaceuticals (NASDAQ: CNSP) is an oncology drug development company specializing in developing anti-cancer drugs for the treatment of primary and metastatic brain and central nervous system cancer. “The first half of fiscal 2022 saw…
-
MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Bridging Gap Between Lidar Concept and Deployment with NVIDIA DRIVE Sim(TM)
Cepton (NASDAQ: CPTN) recently teamed up with NVIDIA to add its lidars into NVIDIA DRIVE Sim(TM) – an end-to-end simulation platform for large-scale, accurate multi-sensor simulation that supports autonomous driving development and validation from concept…
-
MissionIRNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Exec Featured in New Article
Correlate Infrastructure Partners (OTCQB: CIPI) director of corporate business development, Jason Loyet, is featured in a recent article. The article, titled “Get to Know Jason Loyet,” is a Q&A-format piece that provides an overview of…
-
HeartBeam Inc. (NASDAQ: BEAT) Announces New Chief Medical Officer
New Chief Medical Officer will play a major role in defining best paths to adoption, clinical strategies, and partnerships Dr. Fitzgerald serves as director of the Center for Cardiovascular Technology and of the Cardiovascular Core…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches Animal Study to Evaluate Potential Therapeutic Effect of DehydraTECH-CBD on Dementia
Lexaria Bioscience has launched DEM-A22-1, its first-ever study to investigate whether its patented DehydraTECH(TM)-processed CBD may have therapeutic use against dementia The animal study will involve a total of 32 Long Evans rats and will…
-
MissionIRNewsBreaks – Vision Energy Corp. (VIHDD) Announces IBN as Corporate Communications Partner
Vision Energy (OTCQB: VIHDD), a forward-looking energy company developing carbon-reduced solutions for the commercial, industrial and transportation sectors, is partnering with InvestorBrandNetwork (“IBN”) for its corporate communications needs. IBN is a multifaceted financial news and…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Moves to Significantly Expand Land Position at Iska Iska
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) today announced its entry into an option agreement to acquire the Mina Casiterita and Mina Hoyada properties, which collectively cover 14.75 km southwest and west of the…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has closed on a private placement with two healthcare-focused institutional investors. The placement included the sale…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Releases Q3 2022 Financial Report
Freight Technologies (NASDAQ: FRGT), a technology company based on its custom-developed Fr8App platform, which is powered by AI and machine learning and which offers a real-time portal for B2B cross-border shipping and domestic shipping within…
-
Correlate Infrastructure Partners Inc. (CIPI) Eyeing Big Net Gains Following the Enactment of the Inflation Reduction Act; Has Finalized M&A Plans Through Q2 2023 and Posted Revenue Jump
With the recently passed Inflation Reduction Act, Correlate looks to achieve significant net gains The company just posted a significant revenue bump from $236,690 in Q2 2022 to $2,313,577 in Q3 2022, plus shows project…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Releases Q3 2022 Earnings Report and Corporate Update, Plans Earnings Call
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has released its financial results and corporate update for the three- and nine-month periods ended Sept. 30, 2022. The Q3 report milestones include…
-
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Director of Communications and Investor Relations Presents at LD Micro Main Event
BiondVax summarizes collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen to discover and develop nanosized antibody (NanoAb) therapies that address underserved and growing markets, including COVID-19, psoriasis,…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Announces First European Dosing in Potentially Pivotal GBM Trial
The National Brain Tumor Society anticipates that more than 13,000 Americans will receive a GBM diagnosis during 2022, accounting for 49.1% of all primary malignant brain tumors CNS announced the first patient in Europe has…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO Discusses Vast Potential of Autonomous Technology in ‘Get Authentic’ Interview
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, was featured in Get Authentic with Marques Ogden, a podcast series delivering honest, unfiltered and real-time stories from legendary…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Focus on Dementia and Diabetes Featured in New Interview
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in an interview produced by PCG Digital Holdings LLC and published on NewMediaWire. John Docherty, Lexaria’s president and head of research,…
-
Vision Energy Corp. (VIHDD) Accelerates Efforts for Development of Pioneering Green Energy Terminal in North Sea Port of Vlissingen, the Netherlands
Vision Energy is in advanced stages of planning for construction and delivery of Northwestern Europe’s first import, storage and handling terminal designed exclusively for hydrogen carriers, renewable energy products and low-carbon fuels Vision Energy, through…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advancing Research of SPU-21 in Human Synovial Tissue
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Perpetuals.com Ltd (NASDAQ: PDC) CEO to Present at Emerging Growth Conference
- MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q1 2026 Earnings Call and Provide Strategic Updates
- MissionIRNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Scales Digital Lending Capabilities with New Self-Service Feature
- MissionIRNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) CEO Discusses Rare Combination of Grade and Scale in Ambler District
- MissionIRNewsBreaks – GridAI Technologies Corp. (NASDAQ: GRDX) to Present at Market Movers Investor Summit on May 5, 2026